NO20080103L - Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse - Google Patents

Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse

Info

Publication number
NO20080103L
NO20080103L NO20080103A NO20080103A NO20080103L NO 20080103 L NO20080103 L NO 20080103L NO 20080103 A NO20080103 A NO 20080103A NO 20080103 A NO20080103 A NO 20080103A NO 20080103 L NO20080103 L NO 20080103L
Authority
NO
Norway
Prior art keywords
milk
caseins
bioactive
obtaining
methods
Prior art date
Application number
NO20080103A
Other languages
English (en)
Inventor
Isidra Recio Sanchez
Ana Quiros Del Bosque
Blanca Hernandez Ledesma
Jose Angel Gomez Ruiz
Marta Miguel Castro
Maria Lourdes Amigo Garrido
Ivan Lopez Exposito
Maria Mercedes Ramos Gonzalez
Amaya Aleixandre De Artinano
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Publication of NO20080103L publication Critical patent/NO20080103L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sammendrag Oppfinnelsen vedrører fremstillingen av bioaktive produkter som er avledet fra melkeproteiner i fremstillingen av bioaktive melkeprodukter som er avledet fra melkeproteiner, spesielt kaseiner. De 16 oppfinneriske peptidene kan bli fremskaffet kjemisk, bioteknologisk eller ved hjelp av enzymatisk behandling fra proteiner inneholdende de samme og gi opphav til peptider med antimikrobiell aktivitet, en in vitro angiotensinkonverterende enzyminhibitorisk aktivitet og/eller antihypertensiv aktivitet og/eller antioksidantaktivitet. Nevnte næringsmiddelprodukter er egnet for anvendelse i matvareindustrien og den fannasøytiske industrien, både i form av et hydrolysat eller bioaktive peptider.
NO20080103A 2005-06-08 2008-01-07 Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse NO20080103L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200501373A ES2319475B1 (es) 2005-06-08 2005-06-08 Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
PCT/ES2006/070079 WO2006131586A1 (es) 2005-06-08 2006-06-08 Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención

Publications (1)

Publication Number Publication Date
NO20080103L true NO20080103L (no) 2008-03-04

Family

ID=37498152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080103A NO20080103L (no) 2005-06-08 2008-01-07 Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse

Country Status (12)

Country Link
US (1) US8354502B2 (no)
EP (2) EP2495250A3 (no)
JP (1) JP2008545774A (no)
KR (1) KR101343904B1 (no)
CN (2) CN101305017B (no)
AU (1) AU2006256720A1 (no)
BR (1) BRPI0611729A2 (no)
CA (1) CA2611416C (no)
ES (1) ES2319475B1 (no)
MX (1) MX2007015528A (no)
NO (1) NO20080103L (no)
WO (1) WO2006131586A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331202A1 (de) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
AU2007229603A1 (en) * 2006-03-24 2007-10-04 Unilever Plc Healthy food product
DE102006036285A1 (de) * 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
EP2253324A1 (en) * 2009-04-30 2010-11-24 Consejo Superior De Investigaciones Cientificas Use of a casein-derived peptide and compositions thereof as antihypertensive
CA2790996A1 (en) * 2010-02-24 2011-09-01 Morinaga Milk Industry Co. Ltd. Therapeutic agent for eating disorders
CN103232526B (zh) * 2012-12-12 2015-06-24 上海交通大学 一种生物活性多肽lplp及其制备和应用
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
CN103616454B (zh) * 2013-12-06 2015-06-03 贝因美婴童食品股份有限公司 一种定量检测人β-酪蛋白含量的方法以及试剂盒
CN104073539B (zh) * 2014-06-17 2017-03-29 黑龙江省乳品工业技术开发中心 一种牛乳β‑酪蛋白多元活性肽的制备方法及其应用
JP2017048124A (ja) * 2015-08-31 2017-03-09 森永乳業株式会社 アミノペプチダーゼａ阻害剤
EP3170507B1 (en) 2015-11-20 2022-12-21 Consejo Superior de Investigaciones Científicas (CSIC) Antihypertensive peptides from olive oil
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
CN107814838A (zh) * 2017-12-07 2018-03-20 浙江辉肽生命健康科技有限公司 一种生物活性多肽ypqrdmpiqaf及其制备方法和应用
CN107880106B (zh) * 2017-12-11 2020-06-16 浙江辉肽生命健康科技有限公司 一种生物活性多肽vpitptlnre及其制备方法和应用
KR102073824B1 (ko) * 2018-04-11 2020-02-05 강원대학교산학협력단 간 보호용 건강기능식품 및 이의 제조 방법
CN111574585B (zh) * 2019-01-30 2021-10-01 浙江省医学科学院 一种鳕鱼皮寡肽及其分离纯化方法和应用
CN110498833B (zh) * 2019-08-30 2021-01-15 华南理工大学 一种具有ace抑制作用的三肽及其应用
US12359212B2 (en) 2019-11-22 2025-07-15 Mozza Foods, Inc. Recombinant micelle and method of in vivo assembly
US11326176B2 (en) 2019-11-22 2022-05-10 Mozza Foods, Inc. Recombinant micelle and method of in vivo assembly
CN111777665B (zh) * 2020-07-24 2022-07-05 北京林业大学 一种核桃粕抗氧化肽faw及其制备方法与应用
CN115505025A (zh) * 2022-11-10 2022-12-23 东北农业大学 一种基于老年人静态消化模型的乳清蛋白源抗氧化肽的筛选
CN116444619B (zh) * 2022-11-30 2024-07-16 内蒙古伊利实业集团股份有限公司 乳源活性肽ypfpgpihnslp及其制备方法与应用
CN116444608B (zh) * 2022-11-30 2024-06-25 内蒙古伊利实业集团股份有限公司 乳源活性肽dpsffake及其制备方法与应用
CN116444609B (zh) * 2022-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 乳源活性肽lppplpsrwpl及其制备方法与应用
CN118005726A (zh) * 2024-01-31 2024-05-10 上海交通大学 一种来源于驼奶的生物活性肽wpeylkt及其制备方法和应用
CN119170106B (zh) * 2024-11-20 2025-02-11 中国农业大学 一种马乳乳清蛋白源抗氧化肽筛选和制备方法及其应用
CN122036879A (zh) * 2024-11-22 2026-05-15 贵阳学院 一种乳源广谱抗菌肽w-1及其应用
CN121471310A (zh) * 2026-01-07 2026-02-06 深圳保时健生物工程有限公司 一种促骨骼生长牛奶蛋白肽及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444753C2 (de) 1994-12-15 1998-08-06 Forssmann Wolf Georg Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung
US6060448A (en) * 1995-10-31 2000-05-09 Pepsyn Limited Casein fragments having growth promoting activity
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
JP2002532383A (ja) * 1998-09-15 2002-10-02 ニゾ フード リサーチ 生物学的液体からペプチドを製造する方法及びその方法で得られるペプチド
US6514941B1 (en) 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
WO2003018606A2 (en) * 2001-08-30 2003-03-06 Chay 13 Medical Research Group N.V. Casein derived peptides and uses thereof in therapy
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
JP2004519204A (ja) 2000-05-08 2004-07-02 ダビスコ フーズ インターナショナル インコーポレーテッド 抗高血圧ペプチドの生成のための乳漿タンパク質の酵素処理、得られた産物、および哺乳動物における高血圧の処置
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
US7309491B2 (en) * 2003-04-11 2007-12-18 Antigenics Inc. Heat shock protein-based vaccines and immunotherapies
WO2004089986A1 (en) 2003-04-14 2004-10-21 Stichting Voor De Technische Wetenschappen Antimicrobial peptide from transferrin family

Also Published As

Publication number Publication date
BRPI0611729A2 (pt) 2010-10-05
EP2495250A3 (en) 2013-07-10
JP2008545774A (ja) 2008-12-18
KR101343904B1 (ko) 2013-12-23
US8354502B2 (en) 2013-01-15
EP2495250A2 (en) 2012-09-05
ES2319475A1 (es) 2009-05-07
US20100048464A1 (en) 2010-02-25
CN101305017B (zh) 2014-08-06
CA2611416C (en) 2015-10-06
ES2319475B1 (es) 2010-02-16
WO2006131586A1 (es) 2006-12-14
CA2611416A1 (en) 2006-12-14
WO2006131586B1 (es) 2007-02-01
CN103254278B (zh) 2015-07-22
AU2006256720A1 (en) 2006-12-14
CN103254278A (zh) 2013-08-21
EP1905779A1 (en) 2008-04-02
EP1905779A4 (en) 2010-09-01
MX2007015528A (es) 2008-02-25
CN101305017A (zh) 2008-11-12
KR20080045108A (ko) 2008-05-22

Similar Documents

Publication Publication Date Title
EP2495250A3 (en) Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
García et al. Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities
O’Regan et al. Milk proteins
PH12013500348A1 (en) Nutritional products having improved organoleptic properties
NO20071650L (no) Proteinsystemer og matvarer inkludert de samme
WO2008131008A3 (en) Protein hydrolysate compositions having improved sensory characteristics and physical properties
SA112340123B1 (ar) عملية للحصول على نواتج انحلال مائي لبروتين الأرز
NO20083940L (no) Fremgangsmater for redusering av proteinaggregering
WO2011156380A3 (en) Protein-containing adhesives, and manufacture and use thereof
BR112012026906A2 (pt) método para obtenção de produtos nutritivos à base de leguminosas
EP4647504A3 (en) Stabilized lactate responsive enzymes, electrodes and sensors, and methods for making and using the same
DK1996028T3 (da) Faste enzymformuleringer og fremgangsmåde til deres fremstilling
PH12022552035A1 (en) Structured high-protein meat analogue compositions
EP4424368A3 (en) Compositions comprising an urolithin compound
CA3282476A1 (en) Articles including undenatured meat protein and water condensed from steam
PH12019502185A1 (en) Hydrolysed vegetable proteins suitable for use in baby food
WO2008060634A3 (en) Human complement c3 derivatives with cobra venom factor-like function
MX2022009064A (es) Procedimiento para preparar una composicion de consome que puede ser bombeada.
WO2007046891A3 (en) Systems and methods for separating proteins from connective tissue
ATE493999T1 (de) Nahrungsmittel enthaltend dipeptide mit blutdrucksenkenden eigenschaften.
WO2007089923A3 (en) Modifications of cst-ii for increased protein expression
WO2008071755A3 (fr) Peptides derives de la caseine ayant une activité anxiolytique
WO2010058100A8 (fr) Protéines mutantes de la protéine f de piv-5 et de piv-2
EA200800289A1 (ru) Новые ферменты для ферментативного отбеливания пищевых продуктов
WO2008070552A3 (en) Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application